HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Familial hypercholesterolemia treated by plasma exchange and immunoadsorption.

Abstract
IA clearly improved JL's HDL and LDL/HDL ratio because of its specificity, yet the extent of TC and LDL reduction per treatment was not as high as that obtained with TPE. Studies to achieve more efficient and specific extracorporeal lipid removal are in progress to help reduce the risk of CAD in FH patients and others. The continuity of procedural care and supportive needs provided by the nephrology nurses demonstrated a positive influence on J.L.'s acceptance of his familial genetic disorder and the prescribed chronic treatment regimen.
AuthorsR L Wingard
JournalANNA journal (ANNA J) Vol. 20 Issue 1 Pg. 84-5 (Feb 1993) ISSN: 8750-0779 [Print] United States
PMID8431030 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Humans
  • Hyperlipoproteinemia Type II (nursing, therapy)
  • Immunosorbent Techniques
  • Male
  • Plasma Exchange (nursing)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: